Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients

Cardiology Journal

Volumn 16, Issue 2, 2009, Pages 142-145

  Hoseini, Vida Nesar ^a,b   Rasouli, Mehdi ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Fateme Zahra Hospital   (Iran)

Author keywords

Coronary artery disease; Diabetes mellitus; Microalbuminuria

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHELOMETRY; PREVALENCE; PROTEIN URINE LEVEL; URINALYSIS; ALBUMINURIA; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; PHOTOMETRY; RADIOGRAPHY; URINE;

AGED; ALBUMINURIA; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 66349094650     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al. Estimation of contribution of changes in classic risk factor to trends in coronary event rates across the WHO MONICA Project population. Lancet, 2000; 355: 675-678.
2. Messent JW, Elliott TG, Hill RD et al. Prognostic significance of microalbuminuria in insulin depended diabetes mellitus: A 23 years follow up study. Kidney Int, 1992; 41: 836-839.
3. Park HY, Schumock GT, Pickard AS et al. A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes and hypertension. Pharmacotherapy, 2003; 23: 1611-1616.
4. Bigazzi R, Bianchi S, Baldari D et al. Microalbuminuria predict cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens, 1998; 16: 1325-1333.
5. Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy. The LIFE study. Ann Inern Med, 2003; 139: 901-906.
6. Gerstein HC, Mann JF, Yi O et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetes and non diabetes individuals. JAMA, 2001; 266: 421-426.
7. Romundstad S, Holmen J, Kvenild K et al. Microalbuminuria and all cause mortality in 2089 apparently healthy individuals: a 4.4 years follow-up study. Am J Kidney Dis, 2003; 42: 466-473.
8. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol, 2004; 33: 189-198.
9. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Int Med, 2004; 255: 247-256.
10. Klausen K, Borch-Johnsen K, Feldt-Rasmossen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and deaths independently of renal function, hypertension, and diabetes. Circulation, 2004; 110: 32-35.
11. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation, 2002; 106: 1777-1782.
12. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factors for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169.
13. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation, 2005; 111: 1370-1376.
14. Krolewski AS, Warram JH. Natural history of diabetic nephropathy: How much can it be changed? Diabetes Rev, 1995; 3: 446-449.
15. Sukhija R, Aronow WS, Kakar P et al. Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol, 2006; 98: 279-281.
16. Clausen P, Jensen JS, Jensen G et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation, 2001; 103: 1869-1874.
17. Pedrinelli R, Giampietro O, Carmassi F et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet, 1994; 344: 14-18.
18. Meeking DR, Cummings MH, Thorne S et al. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria. Diabetes Med, 1999; 16: 841-847.
19. Festa A, D'Agostino R, Howard G et al. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects, the Insulin Resistance Atherosclerosis Study. Kidney Int, 2000; 58: 1703-1710.
20. Mykkanen L, Zaccaro DJ, Wagenknecht LE et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study. Diabetes, 1998; 47: 793-800.
21. Ibsen H, Wachtell K, Olsen MH et al. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens, 2004; 22: 1805-1811.
22. Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients. Losartan intervention for endpoint reduction in hypertension study. Hypertens, 2005; 45: 198-202.
23. Asselbergs FW, Diercks GF, Hillege HL et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation, 2004; 110: 2809-2816.